JP Morgan Private Wealth Advisors’s Revolution Medicines RVMD Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$913K	Sell	32,996 -12,833	-28%	-$381K	﹤0.01%	1008
2023 Q2	$1.23M	Hold	45,829	–	–	0.01%	709
2023 Q1	$993K	Sell	45,829 -10,943	-19%	-$269K	﹤0.01%	1165
2022 Q4	$1.35M	Hold	56,772	–	–	﹤0.01%	1009
2022 Q3	$1.12M	Sell	56,772 -21,159	-27%	-$465K	﹤0.01%	1079
2022 Q2	$1.52M	Sell	77,931 -21,173	-21%	-$412K	﹤0.01%	945
2022 Q1	$2.53M	Hold	99,104	–	–	0.01%	821
2021 Q4	$2.49M	Hold	99,104	–	–	0.01%	823
2021 Q3	$2.73M	Sell	99,104 -4,598	-4%	-$134K	0.01%	776
2021 Q2	$3.29M	Hold	103,702	–	–	0.01%	702
2021 Q1	$4.76M	Sell	103,702 -5,477	-5%	-$246K	0.02%	522
2020 Q4	$4.32M	Sell	109,179 -24,597	-18%	-$973K	0.01%	522
2020 Q3	$4.66M	Buy	+133,776	New	+$3.71M	0.02%	442

Other funds holding RVMD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

JP Morgan Private Wealth Advisors's RVMD Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors reduced its Revolution Medicines (RVMD) stake by 28% in Q3 2023, selling an estimated $381K and leaving 32,996 shares worth $913K. The position accounts for ﹤0.01% of the portfolio, ranked #1008.

JP Morgan Private Wealth Advisors first reported a position in RVMD in Q3 2020 and has held it in 13 quarters since. The position peaked at $4.76M in Q1 2021. 168 funds tracked by Wall St. Rank hold RVMD as of Q3 2023.

JP Morgan Private Wealth Advisors held 32,996 shares of Revolution Medicines worth $913K as of Q3 2023.
JP Morgan Private Wealth Advisors sold 12,833 Revolution Medicines shares in Q3 2023, an estimated $381K.
Revolution Medicines made up ﹤0.01% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #1008 holding.
JP Morgan Private Wealth Advisors first reported a position in Revolution Medicines in Q3 2020 and has held it in 13 quarters since.
JP Morgan Private Wealth Advisors's Revolution Medicines position peaked at $4.76M in Q1 2021.
168 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.